- China
- /
- Healthcare Services
- /
- SZSE:002788
3 Dividend Stocks Yielding Up To 4.6% For Your Portfolio
Reviewed by Simply Wall St
As global markets experience mixed performances and geopolitical events stir uncertainty, investors are increasingly seeking stable income sources amid record highs in major U.S. stock indexes. In this environment, dividend stocks offer a compelling option for those looking to balance growth with reliable income, as they can provide consistent returns even when market volatility is high.
Top 10 Dividend Stocks
Name | Dividend Yield | Dividend Rating |
Guaranty Trust Holding (NGSE:GTCO) | 6.98% | ★★★★★★ |
Tsubakimoto Chain (TSE:6371) | 4.27% | ★★★★★★ |
CAC Holdings (TSE:4725) | 4.73% | ★★★★★★ |
GakkyushaLtd (TSE:9769) | 4.48% | ★★★★★★ |
Yamato Kogyo (TSE:5444) | 3.97% | ★★★★★★ |
Padma Oil (DSE:PADMAOIL) | 7.44% | ★★★★★★ |
Financial Institutions (NasdaqGS:FISI) | 4.44% | ★★★★★★ |
FALCO HOLDINGS (TSE:4671) | 6.62% | ★★★★★★ |
Citizens & Northern (NasdaqCM:CZNC) | 5.53% | ★★★★★★ |
Banque Cantonale Vaudoise (SWX:BCVN) | 5.41% | ★★★★★★ |
Click here to see the full list of 1926 stocks from our Top Dividend Stocks screener.
Let's uncover some gems from our specialized screener.
Luyan PharmaLtd (SZSE:002788)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Luyan Pharma Co., Ltd. is involved in the research, development, production, and sale of human health products in China and has a market cap of CN¥3.55 billion.
Operations: Luyan Pharma Co., Ltd.'s revenue segments are not specified in the provided text.
Dividend Yield: 3.3%
Luyan Pharma Ltd. has a dividend yield of 3.28%, placing it in the top 25% of CN market dividend payers. Its dividends are well-covered by earnings and cash flows, with a payout ratio of 32.3% and a cash payout ratio of 23.3%. Despite stable payments over nine years, its debt coverage by operating cash flow is weak. Recent earnings show slight growth, with net income at CNY 257.35 million for the first nine months of 2024.
- Click here and access our complete dividend analysis report to understand the dynamics of Luyan PharmaLtd.
- Our expertly prepared valuation report Luyan PharmaLtd implies its share price may be lower than expected.
Idemitsu KosanLtd (TSE:5019)
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Idemitsu Kosan Co., Ltd. operates in the petroleum, basic chemicals, functional materials, power and renewable energy, and resources sectors both in Japan and internationally with a market cap of ¥1.37 trillion.
Operations: Idemitsu Kosan Co., Ltd. generates revenue from several segments, including Petroleum with ¥7.67 billion, Basic Chemicals at ¥660.07 million, Highly Functional Materials totaling ¥543.61 million, Resources contributing ¥273.14 million, and Power and Renewable Energy bringing in ¥138.70 million.
Dividend Yield: 3.4%
Idemitsu Kosan Ltd. offers a dividend yield of 3.44%, slightly below the top quartile in the JP market, but its dividends are well-supported by a low payout ratio of 28.8% and cash flow coverage at 14.9%. Recent dividend increases reflect stable growth over the past decade. Despite high debt levels, earnings have grown by 18.3% last year, supporting reliable dividends amidst strategic expansions in innovative battery materials and carbon-neutral initiatives.
- Unlock comprehensive insights into our analysis of Idemitsu KosanLtd stock in this dividend report.
- The analysis detailed in our Idemitsu KosanLtd valuation report hints at an deflated share price compared to its estimated value.
SintokogioLtd (TSE:6339)
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Sintokogio, Ltd., along with its subsidiaries, manufactures and sells foundry, surface treatment, environmental, and material handling products both in Japan and internationally, with a market cap of ¥49.31 billion.
Operations: Sintokogio, Ltd. generates revenue through its diverse operations in foundry, surface treatment, environmental solutions, and material handling sectors across domestic and international markets.
Dividend Yield: 4.7%
Sintokogio Ltd. offers a dividend yield of 4.68%, placing it in the top 25% of JP market payers, with dividends growing steadily over the past decade. However, these payments are not supported by free cash flows and rely on earnings coverage due to a low payout ratio of 17.3%. While earnings have grown at an impressive rate of 32% annually over five years, large one-off items affect financial results' quality and sustainability.
- Click to explore a detailed breakdown of our findings in SintokogioLtd's dividend report.
- Our comprehensive valuation report raises the possibility that SintokogioLtd is priced higher than what may be justified by its financials.
Where To Now?
- Investigate our full lineup of 1926 Top Dividend Stocks right here.
- Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
- Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Ready For A Different Approach?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:002788
Luyan PharmaLtd
Engages in the research and development, production, and sale of human health products in China.
Good value with adequate balance sheet and pays a dividend.